Literature DB >> 35027362

Covid-19: WHO recommends baricitinib and sotrovimab to treat patients.

Zosia Kmietowicz1.   

Abstract

Entities:  

Year:  2022        PMID： 35027362     DOI： 10.1136/bmj.o97

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Comparative evaluation of authorized drugs for treating Covid-19 patients.

Authors:  Towhidul Islam; Moynul Hasan; Mohammad Saydur Rahman; Md Rabiul Islam
Journal:  Health Sci Rep       Date:  2022-06-13

Review 2.  Efficacy of COVID-19 treatments among geriatric patients: a systematic review.

Authors:  Helen Senderovich; Danusha Vinoraj; Madeline Stever; Sarah Waicus
Journal:  Ther Adv Infect Dis       Date:  2022-06-01

Review 3.  JAK inhibitors and COVID-19.

Authors:  Gabriel Levy; Paola Guglielmelli; Peter Langmuir; Stefan N Constantinescu
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 12.469

Review 4.  A Comprehensive Overview of Globally Approved JAK Inhibitors.

Authors:  Ahmed M Shawky; Faisal A Almalki; Ashraf N Abdalla; Ahmed H Abdelazeem; Ahmed M Gouda
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525

5.  Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.

Authors:  Andrés López-Cortés; Santiago Guerrero; Esteban Ortiz-Prado; Verónica Yumiceba; Antonella Vera-Guapi; Ángela León Cáceres; Katherine Simbaña-Rivera; Ana María Gómez-Jaramillo; Gabriela Echeverría-Garcés; Jennyfer M García-Cárdenas; Patricia Guevara-Ramírez; Alejandro Cabrera-Andrade; Lourdes Puig San Andrés; Doménica Cevallos-Robalino; Jhommara Bautista; Isaac Armendáriz-Castillo; Andy Pérez-Villa; Andrea Abad-Sojos; María José Ramos-Medina; Ariana León-Sosa; Estefanía Abarca; Álvaro A Pérez-Meza; Karol Nieto-Jaramillo; Andrea V Jácome; Andrea Morillo; Fernanda Arias-Erazo; Luis Fuenmayor-González; Luis Abel Quiñones; Nikolaos C Kyriakidis
Journal:  Front Pharmacol       Date:  2022-03-29       Impact factor: 5.810

Review 6.  Current challenges in different approaches to control COVID-19: a comprehensive review.

Authors:  Simran Giri; Sanjukta Sen; Rohan Singh; Paramita Paul; Ranabir Sahu; Gouranga Nandi; Tarun Kumar Dua
Journal:  Bull Natl Res Cent       Date:  2022-03-03

Review 7.  COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

Authors:  Wei Shen Ho; Ruirui Zhang; Yeong Lan Tan; Christina Li Lin Chai
Journal:  Pharmacol Res       Date:  2022-04-01       Impact factor: 10.334

8.  Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.

Authors:  Puja Mehta; Boghuma K Titanji
Journal:  Lancet       Date:  2022-07-30       Impact factor: 202.731
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.